Ab initio study of C14 laves phases in Fe-based systems by Pavlu J., Šob M.

Get full text

Modelling of phase equilibria in the Hf-V system below room temperature by Vřešťál J., Pavlů J., Wdowik U.D., Šob M.

Get full text

Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy by Loke, J, Metzner, M, Boucher, R, Jackson, A, Hopkins, L, Pavlu, J, Tholouli, E, Drummond, M, Peniket, A, Bishop, R, Fox, S, Vyas, P, Craddock, C

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. by Chaidos, A, Patterson, S, Szydlo, R, Chaudhry, M, Dazzi, F, Kanfer, E, McDonald, D, Marin, D, Milojkovic, D, Pavlu, J, Davis, J, Rahemtulla, A, Rezvani, K, Goldman, J, Roberts, I, Apperley, J, Karadimitris, A

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT. by Innes, A, Beattie, R, Sergeant, R, Damaj, D, Foroni, L, Marin, D, Kanfer, E, Mielke, S, Milojkovic, D, MacDonald, D, Pavlu, J, Rahemtulla, A, Roberts, I, Slade, D, Bray, E, Goldman, J, Apperley, J, Szydlo, R, Dazzi, F, Rezvani, K

Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia by Craddock, C, Jackson, A, Loke, J, Siddique, S, Hodgkinson, A, Mason, J, Andrew, G, Nagra, S, Malladi, R, Peniket, A, Gilleece, M, Salim, R, Tholouli, E, Potter, V, Crawley, C, Wheatley, K, Protheroe, R, Vyas, P, Hunter, A, Parker, A, Wilson, K, Pavlu, J, Byrne, J, Dillon, R, Khan, N, McCarthy, N, Freeman, SD